Rapidly Progressive Glomerulonephritis Enrolling by Invitation Phase 2 / 3 Trials for Methylprednisolone (DB00959)

IndicationStatusPhase
DBCOND0079353 (Rapidly Progressive Glomerulonephritis)Enrolling by Invitation2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02647255Trial of Plasma Exchange for Severe Crescentic IgA NephropathyTreatment